Join our community of smart investors

Kainos: orderbook underpins future growth

The provider of digital services and platforms saw its order backlog rise 45 per cent
May 29, 2018

Kainos’s (KNOS) shares were on the rise on news that the IT group enjoyed its eighth consecutive year of revenue and adjusted pre-tax profit growth, with the latter rising 7 per cent to £15.2m. It was also a period of continued diversification away from the company’s core markets; international revenues climbed 18 per cent to £20.2m, while commercial revenue – as opposed to governmental – was up 19 per cent to £29.1m.

IC TIP: Buy at 402p

Diversity aside, sales orders were the star metric within these results, jumping a whopping 38 per cent to £131m, buoyed by better software-as-a-service bookings. In turn, this meant that Kainos’s backlog – the value of contracted revenue yet to be recognised – shot up 45 per cent to £76.4m, laying the foundations for future growth.  

By business area, digital services saw revenue growth of 22 per cent to £78.6m. Here, the digital transformation segment works with central government departments including the Home Office and the Cabinet Office. Reassuringly, for now, bosses have not identified any Brexit-related repercussions for such programmes. Moreover, the group has also prioritised its commercial customer base; this expanded from 42 to 47.

Elsewhere in digital services, Kainos maintained its position as a leading Workday partner – signing 39 new clients against just 12 a year earlier. Workday provides cloud-based systems for human resources and financial management, and has become increasingly focused on the UK public sector.

The group’s smaller business, digital platforms, comprises three separate products – Smart Automated Testing, Evolve Electronic Medical Record and Evolve Integrated Care. The division saw relatively meagre revenue growth of 4 per cent to £15.9m. Both Evolve products faced NHS funding difficulties during the year, but – implying some improvement in the wider market – their combined sales orders rose from £7.8m to £10m. And the pipeline for Evolve IC looks strong, despite its progress in the US hitting a stumbling block when InTouchHealth cancelled its contract. The group must now accelerate talks with other US-based partners.

Broker Investec forecasts pre-tax profits of £17.4m and EPS of 11.6p for the year to March 2019, against £14.2m and 9.7p for FY2018.

KAINOS (KNOS)   
ORD PRICE:402pMARKET VALUE:£476m
TOUCH:392-405p12-MONTH HIGH:409pLOW: 217p
DIVIDEND YIELD:1.6%PE RATIO:40
NET ASSET VALUE:30pNET CASH:£29m
Year to 31 MarTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
201441.97.1nana
201560.811.88.9na
201676.614.310.76.0
201783.513.38.96.3
201896.714.310.06.6
% change+16+7+12+5
Ex-div:20 Sep   
Payment:19 Oct   
*Kainos listed its shares in July 2015